Gulf war illnesses: Causes and controversies

Mayo Clinic Proceedings

Volumn 75, Issue 8, 2000, Pages 811-819

  Sartin, Jeffrey S ^a,b  

^a LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^b Internal Medicine Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHEMICAL WARFARE AGENT; DOXYCYCLINE; ORGANOPHOSPHATE PESTICIDE; PERMETHRIN; PYRIDOSTIGMINE; SARIN; SOMAN;

ARTICLE; BACTERIAL INFECTION; CHEMICAL WARFARE; CULTURAL FACTOR; HUMAN; MILITARY MEDICINE; MYCOPLASMA; PERSIAN GULF SYNDROME; PSYCHOLOGICAL ASPECT; SOLDIER; SYMPTOMATOLOGY; SYNDROME DELINEATION; TOXIN ANALYSIS;

EID: 0033883705     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.8.811     Document Type: Article

References (110)

1. Presidential Advisory Committee on Gulf War Veterans' Illnesses. Final Report. Washington, DC: US Government Printing Office; December 1996. Available at: www.gwvi.ncr.gov /toc-f.html. Accessed May 18, 2000.
2. DeFraites RF, Wanat ER, Norwood AE, Williams S, Cowan D, Callahan T. Investigation of a Suspected Outbreak of an Unknown Disease Among Veterans of Operation Desert Shield/Storm, 123rd Army Reserve Command, Fort Benjamin Harrison, Indiana, April 1992. Washington, DC: Walter Reed Army Institute of Research; 1992.
3. Brown D. Triumphant in the desert, striken at home. Washington Post. July 24, 1994; sect A: 1.
4. Department of Defense. Comprehensive Clinical Evaluation Program (CCEP)for Gulf War Veterans-Report on 10,020 Participants. Washington, DC: Dept of Defense, US Government Printing Office; August 1995.
5. McAllister B. Compassion may take act of Congress: veterans agency balked at early response on Gulf War problem. Washington Post. July 25, 1994; sect A:l.
6. Blair M. Government lying to vets about Gulf War syndrome. Conspiracy Nation. 1995;7:43. Available at: www.skientology .org/0012.html. Accessed May 11, 2000.
7. Bernstein D. Gulf War Syndrome covered up. Covert Action Quarterly. August 1, 1995. Available at: www.gulfweb.org /doc_show.cfm?ID=233. Accessed May 11, 2000.
8. Hersh SM. Against All Enemies: Gulf War Syndrome: The War Between America's Ailing Veterans and Their Government. New York, NY: Ballantine Books; 1998.
9. Department of Defense. US demolition operations at the Khamisiyah ammunition storage point. Gulflink: Office of the Special Assistant for Gulf War Illnesses. April 14, 1997. Available at: www.gulflink.osd.mil/khamisiyahJ. Accessed May 11,2000.
10. Newman RJ. Gulf War mysteries: why Americans may never know what's making these veterans sick. US News [serial online]. November 25, 1996. Available at: www.usnews.com/usnews /issue/25vets.htm. Accessed May 11, 2000.
11. Feinstein AR. Nosologie challenges of diagnostic criteria for a "new illness." In: Proceedings of the Conference on Federally Sponsored Gulf War Veterans' Illnesses Research, June 17-19, 1998. Washington, DC: Dept of Health and Human Services, US Government Printing Office; 1998.
12. Joseph SC, Comprehensive Clinical Evaluation Program Evaluation Team. A comprehensive clinical evaluation of 20,000 Persian Gulf War veterans. MilMed. 1997;162:149-155.
13. Roy MJ, Koslowe PA, Kroenke K, MagruderC. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the Comprehensive Clinical Evaluation Program. PsychosomMed. 1998;60:663-668.
14. Department of Defense. Comprehensive Clinical Evaluation Report on 1898 Participants. Washington, DC: Dept of Defense, US Government Printing Office; 1996.
15. Centers for Disease Control and Prevention. Unexplained illness among Persian Gulf War veterans in an Air National Guard unit: preliminary report-August 1990-March 1995. MMWR Morb Mortal Wkly Rep. 1995;44:443-447.
16. Iowa Persian Gulf Study Group. Self-reported illness and health status among Gulf War veterans: a population-based study. JAMA. 1997;277:238-245.
17. Kang HA, Bullman TA. Mortality among US veterans of the Persian Gulf War. N EnglJ Med. 1996; 335:1498-1504.
18. Writer JV, DeFraites RF, Brundage JF. Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA. 1996;275:118-121.
19. Gray GC, Coate BD, Anderson CM, et al. The postwar hospitalization experience of US veterans of the Persian Gulf War. N Engl J Med. 1996;335:1505-1513.
20. Institute of Medicine. Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems. Washington. DC: National Academy Press; 1996. Available at: books.nap.edu/books/0309055369/html/index .html. Accessed July 5, 2000.
21. Unwin C, Blatchley N, Coker W, et al. Health of UK servicemen who served in Persian Gulf War. Lancet. 1999:353:169-178.
22. Ismail K, Everitt B, Blatchley N, et al. Is there a Gulf War syndrome? Lancet. 1999;353:179-182.
23. Gray GC, Smith TC, Kang HK, Knoke JD. Are Gulf War veterans suffering war-related illnesses? federal and civilian hospitalizations examined, June 1991 to December 1994. Am J Epidemiol. 2000:151:63-71.
24. Cowan DN, DeFraites RF, Gray GC, Goldenbaum MB, Wishik SM. The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med. 1997:336:1650-1656.
25. Haley RW, Kurt TL, Horn J. Is there a Gulf War syndrome? searching for syndromes by factor analysis of symptoms [published correction appears in JAMA. 1997;278:388]. JAMA. 1997:277:215-222.
26. Ishoy T, Guldager B, Appleyard M, Suadicani P, Hein HO, Gyntelberg F. Health status after serving in the Gulf War area: the Danish Gulf War Study [in Danish]. Ugeskr Laeger. 1999;161: 5423-5428.
27. Landrigan PJ. Illness in Gulf War veterans: causes and consequences [editorial]. JAAM. 1997:277:259-261.
28. Landrigan PJ. Identification of Gulf War syndrome: methodological issues and medical illnesses [letter]. JAMA. 1997:278:387.
29. Fukuda K, Nisenbaum R, Stewart G, et al. Chronic multisymptom illness affecting air force veterans of the Gulf War. JAMA. 1998; 280:981-988.
30. Buchwald D. Overlapping syndromes. In: Proceedings of the Conference on Federally Sponsored Gulf War Veterans' Illnesses Research. June 17-19.1998. Washington, DC: Dept of Health and Human Services, US Government Printing Office; 1998.
31. Hyams KC, Wignall FS, Roswell R. War syndromes and their evaluation: from the US Civil War to the Persian Gulf War. Ann Intern Med. 1996;125:398-405.
32. Straus SE. Bridging the gulf in war syndromes. Lancet. 1999; 353:162-163.
33. Department of Defense, CIA. US troop exposure during Khamisiyah demolitions not found at dangerous levels. Gulflink: information about Khamisiyah. August 19, 1997. Available at: www.gulflink.osd.mil/news/na_plume 081997.htm. Accessed May 11.2000.
34. Gray GC, Smith TC, Knoke JD, Heller JM. The postwar hospitalization experience of Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq. Am J Epidemiol. 1999; 150:532-540.
35. Department of Defense. Case narratives/information papers. Gulflink: Office of the Special Assistant for Gulf War Illnesses. Available at: www.gulflink.osd.mil/narr_index.html. Accessed May 11,2000.
36. Department of Defense. M8A1 automatic chemical agent alarm. Gulflink: Office of the Special Assistant for Gulf War Illnesses. October 30, 1997. Available at: www.gulflink.osd.mil/m8alalarmsJ. Accessed May 11,2000.
37. Department of Defense. OSAGW1 report reveals "likely" case of mustard agent exposure. Gulflink: Office of the Special Assistant for Gulf War Illnesses. September 10, 1997. Available at: www.gulf link.osd.mil/news/na_must_expo090997.htm. Accessed on May 11,2000.
38. Office of the Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses. Annual Report, November 1998. Available at: www.gulflink.osd.mil/library/annual/annual_99_report .html. Accessed May 11, 2000.
39. Department of Defense. Report on possible effects of organophosphate "low-level" nerve agent exposure. Gulflink: Office of the Special Assistant for Gulf War Illnesses. Available at: www .guinink.osd.mil/finalagt.htm. Accessed July 5, 2000.
40. Gordon JJ, Inns RH, Johnson MK, et al. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch Toxicol. 1983;52:71-82.
41. Bucci TJ, Parker RM, Gosnell PA. Delayed Neuropathy Study of Sarin, Type I and Type II, in SPF White Leghorn Chickens (US Army Project 3M1-61102BS15). Jefferson, Ark: National Center for Toxicological Research: 1992.
42. Crowell JA, Parker RM, Bucci TJ, Dacre JC. Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol. 1989; 4:15-20.
43. Nakajima T, Sato S, Morita H, Yanagisawa N. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. J Occup Environ Med. 1997;54:697-701.
44. Murata K. Araki S, Yokoyama K. Asymptomatic sequelae to acute sarin poisoning in the central and autonomie nervous system 6 months after the Tokyo subway attack. J Neural. 1997;244:601 -606.
45. Committee on Toxicology, National Research Council. Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents. Vol 1-3. Washington, DC: National Academy Press; vol 1, 1982; vol 2, 1984; vol 3, 1985.
46. Baker DJ. Sedgwick EM. Single fibre electromyographic changes in man after organophosphate exposure. Hum Exp Toxicol. 1996:15:369-375.
47. Perrotta DM, Environment Committee Armed Forces Epidemiological Board. Long-term health effects associated with sub-clinical exposures to GB and mustard. Gulflink: Office of the Special Assistant for Gulf War Illnesses. July 18, 1996. Available at: www.gultlink.osd.mil/agem.html. Accessed May 11, 2000.
48. Haley RW, Kurt TL. Wolfe GI, et al. Identification of Gulf War syndrome: methodological issues and medical illnesses [letter]. JAMA. 1997:278:385-386.
49. Roland PS, Haley RW, Yellin W, Owens K, Shoup AG. Vestibular dysfunction in Gulf War syndrome. Otolaryngol Head Neck Surg. 2000; 122:319-329.
50. Amato AA, Jackson C, McVey A. Identification of Gulf War syndrome: methodological issues and medical illnesses [letter]. JAMA. 1997;278:384-385.
51. Amdur MO, Doull J, eds. Casarett and Dou/l's Toxicology: The Basic Science of Poisons. 5th ed. New York, NY: McGraw-Hill; 1996.
52. Clegg DJ, van Gemert M. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. J Toxicol Em-iron Health B C rit Rev. 1999;2:257-279.
53. Khurana D, Prabhakar S. Organophosphorus intoxication. Arch Neural. 2000:57:600-602.
54. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War: a cross-sectional epidemiologic study..MAM. 1997:277:231-237.
55. Drake-Baumann R, Seil FJ. Effects of exposure to low-dose pyridostigmine on neuromuscular junctions in vitro. Muscle Nerve. 1999;22:696-703.
56. van Haaren F, De Jongh R, Hoy JB, et al. The effects of acute and repeated pyridostigmine bromide administration on response acquisition with immediate and delayed reinforcement. Pharmacol Biochem Behav. 1999;62:389-394.
57. Servatius RJ, Ottenweller JE, Beldowicz D, Guo W, Zhu G. Natelson BH. Persistently exaggerated startle responses in rats treated with pyridostigmine bromide. J Pharmacol Exp Ther. 1998;287:1020-1028.
58. Lallement G, Foquin A, Baubichon D, Burckhart MF, Carpentier P, Canini F. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs. Neurotoxicology. 1998; 19:759-766.
59. US Senate Committee on Veterans' Affairs, /s Military Research Hazardous to Veterans' Health? Lessons Spanning Half a Century. Washington, DC: US Government Printing Office; 1994.
60. Moss JI. Synergism of toxicity of AVV-diethyl-m-toluamide to German cockroaches (Othoptera: Blattellidae) by hydrolytic enzyme inhibitors. J Econ Entomol. 1996;89:1151 -1155.
61. Abou-Donia MB, Wilmarth KR, Abdel-Rahman AA, Jensen KF, Oehme FW, Kurt TL. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. FundamApplToxicol. 1996;34:201-222.
62. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health. 1996;48:35-56.
63. Acute Oral Toxicity Study or Pyridostigmine Bromide, Permethrin and DEET in the Laboratory Rat. Aberdeen Proving Ground, Md: US Army Center for Health Promotion and Preventive Medicine; 1995. Fact sheet 75-48-2665.
64. Buchholz BA, Pawley NH, Vogel JS, Mauthe RJ. Pyrethroid decrease in central nervous system from nerve agent pretreatment. JAppIToxicol. 1997; 17:231-234.
65. Persian Gulf Veterans' Coordinating Board Research Working Group. Annual report to Congress-1998: research on Gulf War veterans' illnesses. Available at: www.va.gov/resdev/pgulf98 /gwrpt98.htm. Accessed May 11, 2000.
66. Haley RW, Horn J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans: a blinded case-control study. JAMA. 1997;277:223-230.
67. Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol. 1999; 157: 227-233.
68. Kurt TL. Epidemiological association in US veterans between Gulf War illness and exposures to anticholinesterases. Toxicol Lett. 1998;102-103:523-526.
69. Hyams KC, Wignall FS. Identification of Gulf War syndrome: methodological issues and medical illnesses [letter]. JAMA. 1997;278:384.
70. Amato AA, McVey A, Cha C, et al. Evaluation of neuromuscular symptoms in veterans of the Persian Gulf War. Neurology. 1997; 48:4-12.
71. Ismail K, Everitt B, David A, Wessely S. Is there a Gulf War syndrome? [letter]. Lancet. 1999;354:1645-1646.
72. Engel CC Jr, Jing Z. Identification of Gulf War syndrome: methodological issues and medical illnesses [letter], JAMA. 1997;278: 383-384.
73. Reeves WC, Fukuda K, Nisenbaum R, Thompson WW. Chronic multisystem illness among Gulf War veterans [letter]. JAMA. 1999;282:328-329.
74. Brown D. $3 Million study of Gulf War illnesses criticized: Pentagon bypassed competitive procedures in picking researcher who sees several "syndromes." Washington Post. November 8, 1997; sect A: 10.
75. VA studies effects of depleted uranium exposure on friendly fire victims. Gulflink: Office of the Special Assistant for Gulf War Illnesses. May 8, 2000. Available at: www.gulflink.osd.mil/news /na_du_health_9mayOO.html. Accessed May 11, 2000.
76. Environmental exposure report: depleted uranium in the Gulf. Gulflink: Office of the Special Assistant for Gulf War Illnesses. July 31, 1998. Available at: www.gulflink.osd.mil/duJ. Accessed May 11,2000.
77. Environmental exposure report: oil well fires. Gulflink: Office of the Special Assistant for Gulf War Illnesses. October 13, 1998. Available at: www.gulflink.osd.mil/oiLwell_firesJ. Accessed May 11,2000.
78. Gerrity TR. Overview of the federal research program. In: Proceedings of the Conference on Federally Sponsored Gulf War Veterans' Illnesses Research, June 17-19,1998. Washington, DC: Dept of Health and Human Services, US Government Printing Office; 1998.
79. The possible role of vaccine adjuvants in Persian Gulf War veterans' illnesses. Gulflink: Office of the Special Assistant for Gulf War Illnesses. March 1996. Available at: www.gulflink.osd.mil /finalrpt.html. Accessed May 11, 2000.
80. Korenyi-Both AL, Korenyi-Both AL, Juncer DJ. AI Eskan disease: Persian Gulf syndrome. Mil Med. 1997;162:1-13.
81. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999;54:147-149.
82. Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry veterans. Arch Environ Health. 1999;54:313-318.
83. Black DW, Doebbeling BN, Voelker MD, et al. Multiple chemical sensitivity syndrome: symptom prevalence and risk factors in a military population. Arch Intern Med. 2000; 160:1169-1176.
84. Urnovitz HB. Testimony to House Committee on Government Reform and Oversight, Subcommittee on Human Resource and Intergovernmental Relations. March 28, 1996. Available at: www.chronicillnet.org/PGWS/Testimony.html. Accessed May 11,2000.
85. Urnovitz HB, Tuite JJ, Higashida JM, Murphy WH. RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22qll.2. ClinDiagnLabImmunol. 1999;6:330-335.
86. Cabell B. Doctor to test bacteria theory for Gulf War syndrome. CNN Interactive, US News Story Page. February 19, 1997. Available at: www.cnn.com/US/9702/19/gulf.warJ. Accessed May 11, 2000.
87. Department of Defense. A guide to Gulf War veterans' health. Gulflink: Office of the Special Assistant for Gulf War Illnesses. March 1998. Available at: www.gulflink.osd.mil/va_health.html. Accessed July 5, 2000.
88. Nicolson GL, Nicolson NL. Mycoplasma infections in Gulf War illnesses: results of a preliminary study on the prevalence of mycoplasmal infections in Desert Storm veterans with chronic fatigue and other symptoms. Presented to: President's Panel on Gulf War Illnesses; August 14-16, 1995; Washington, DC. Available at: www.immed.org/testimony/gulf_war_illness/prspnl.html. Accessed July 6, 2000.
89. Nicolson GL, Rosenberg-Nicolson NL. Doxycycline treatment and Desert Storm [letter]. JAMA. 1995;273:618-619.
90. Nicolson GL, Nicolson NL. Gulf War illnesses: complex medical, scientific and political paradox. Med Confl Surviv. 1998;14:156165.
91. Gray GC, Kaiser KS, Hawksworth AW, Watson HL. No sérologie evidence of an association found between Gulf War service and Mycoplasma fermentons infection. Am J Trop Med Hyg. 1999; 60:752-757.
92. Shenon P. Study links chemicals to sick veterans. New York Times [serial online]. June 15, 1997. Available at: www.nytimes.com
93. Stretch RH, Bliese PD, Marlowe DH, Wright KM, Knudson KH, Hoover CH. Psychological health of Gulf War-era military personnel. Mil Med. 1996; 161:257-261.
94. Stretch RH, Marlowe DH, Wright KM, Bliese PD, Knudson KH, Hoover CH. Post-traumatic stress disorder symptoms among Gulf War veterans. Mil Med. 1996; 161:407-410.
95. Morgan CA III, Grillon C, Southwick SM, Davis M, Charney DS. Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder. Am J Psychiatry. 1996; 153:64-68.
96. Ryan-Wenger NM. Physical and psychosocial impact of activation and deactivation on army reserve nurses. Mil Med. 1992; 157: 447-452.
97. Dlugosz LJ, Hocter WJ, Kaiser KS, et al. Risk factors for mental disorder hospitalization after the Persian Gulf War: US Armed Forces, June 1, 1991-September 30, 1993. ./ din Epidemiol. 1999;52:1267-1278.
98. Gray GC, Kaiser KS, Hawksworth AW, Hall FW, Barrett-Connor E. Increased postwar symptoms and psychological morbidity among US Navy Gulf War veterans. Am J Trop Med Hyg. 1999; 60:758-766.
99. Engel CC Jr, Ursano R, Magruder C, et al. Psychological conditions diagnosed among veterans seeking Department of Defense care for Gulf War-related health concerns. J Occup Environ Med. 1999;41:384-392.
100. Crofford, LJ. The biology of stress. In: Proceedings of the Conference on Federally Sponsored Gulf War Veterans' Illnesses Research, June 17-19. 1998. Washington, DC: Dept of Health and Human Services, US Government Printing Office; 1998.
101. American Psychiatrie Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington. DC: American Psychiatrie Association; 1994:424-429.
102. Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. 7th ed. Baltimore, Md: Williams & Wilkins; 1994:606-611.
103. Nicolson GL, Hyman E, Korenyi-Both A, et al. Progress on Persian Gulf War illnesses. IntJOccup Med Toxicol. 1995; 1:365370.
104. Everson MP, Kotler S, Blackburn WD Jr. Stress and immune dysfunction in Gulf War veterans. Ann N Y Acad Sei. 1999;876: 413-418.
105. Sillanpaa MC, Agar LM, Axelrod BN. Minnesota Muhiphasic Personality Inventory-2 validity patterns: an elucidation of Gulf War syndrome. Mil Med. 1999; 164:261-263.
106. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910-921.
107. Ross SE. "Mêmes" as infectious agents in psychosomatic illness. Ann Intern Med. 1999; ! 31:867-871.
108. Clauw DJ. Treating difficult to diagnose and ill-defined conditions: translating new advances in our understanding of mechanisms into more effective treatments. In: Proceedings of the Conference on Federally Sponsored Gulf War Veterans' Illnesses Research, June 17-19,1998. Washington, DC: Dept of Health and Human Services, US Government Printing Office; 1998.
109. Hodgson MJ, Kipen HM. Gulf War illnesses: causation and treatment. J Occup Environ Med. 1999:41:443-452.
110. Gerrity TR, Feussner JR. Emerging research on the treatment of Gulf War veterans' illnesses. J Occup Environ Med. 1999;41:440-442.